Immunotherapy to Have Emerging Role in Squamous Cell Lung Cancer – OncLive
OncLive |
Immunotherapy to Have Emerging Role in Squamous Cell Lung Cancer
OncLive Beyond the May 2017 FDA approval of pembrolizumab (Keytruda) plus carboplatin/pemetrexed for nonsquamous patients regardless of PD-L1 status, researchers are turning their focus to immunotherapy combinations in squamous patients in ongoing … 5 Lung Cancer Treatments Helping Mesothelioma Patients |
